Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076562457> ?p ?o ?g. }
- W2076562457 endingPage "2403" @default.
- W2076562457 startingPage "2398" @default.
- W2076562457 abstract "3'-Azido-3'-deoxythymidine (AZT) is a drug of choice for the treatment of AIDS. On the basis of pharmacokinetic data, the nonhuman primate Macaca nemestrina has been shown to be a suitable animal model for use in the study of the disposition of AZT. However, since AZT is activated to its metabolite, the AZT triphosphate (AZTTP), intracellularly, we investigated the intracellular activation of AZT in peripheral blood mononuclear cells (PBMCs) of healthy and simian immunodeficiency virus-infected macaques and compared it with that in PBMCs obtained from human volunteers. At 5 microM extracellular AZT, both human and macaque PBMCs rapidly convert AZT to AZT monophosphate (AZTMP) (84% of total phosphorylated products) in 4 h. Increases in AZTMP levels of 7.7- and 12-fold were observed in human and macaque PBMCs, respectively, when the extracellular AZT concentration increased from 0.45 to 14.4 microM. Similar ratios of AZT metabolites, AZT diphosphate (AZTDP)/AZTTP (0.7 to 1.4), AZTMP/AZTDP (3 to 14), and AZTMP/AZTTP (3 to 19), over the same AZT concentration range were observed in both human and macaque PBMCs, suggesting that these cells have similar capacities to phosphorylate AZT. Simian immunodeficiency virus-infected macaque PBMCs showed a fivefold increase in intracellular AZT and AZTMP levels and a twofold increase in AZTDP and AZTTP levels (picomoles per 10(7) cells) when compared with those in the uninfected cells (at 4 h with 0.9 microM extracellular concentration). This increase in AZT metabolite levels has also been reported for human immunodeficiency virus-infected PBMCs. Collectively, given the similarities in phosphorylation profiles between healthy and infected human and macaque PBMCs, we conclude that the macaque is a suitable animal model for use in the study of factors that can effect the in vivo phosphorylation of AZT." @default.
- W2076562457 created "2016-06-24" @default.
- W2076562457 creator A5022348442 @default.
- W2076562457 creator A5030716811 @default.
- W2076562457 creator A5041636907 @default.
- W2076562457 creator A5045487241 @default.
- W2076562457 date "1994-10-01" @default.
- W2076562457 modified "2023-09-25" @default.
- W2076562457 title "Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells" @default.
- W2076562457 cites W1502121617 @default.
- W2076562457 cites W1502628406 @default.
- W2076562457 cites W1503253993 @default.
- W2076562457 cites W1518374344 @default.
- W2076562457 cites W1548955637 @default.
- W2076562457 cites W1553637501 @default.
- W2076562457 cites W1979161571 @default.
- W2076562457 cites W1993412676 @default.
- W2076562457 cites W1993834400 @default.
- W2076562457 cites W1994613586 @default.
- W2076562457 cites W2013746182 @default.
- W2076562457 cites W2019265347 @default.
- W2076562457 cites W2045777528 @default.
- W2076562457 cites W2054620412 @default.
- W2076562457 cites W2072246943 @default.
- W2076562457 cites W2080452440 @default.
- W2076562457 cites W2086231318 @default.
- W2076562457 cites W2089457303 @default.
- W2076562457 cites W2089932711 @default.
- W2076562457 cites W2093943927 @default.
- W2076562457 cites W2095347346 @default.
- W2076562457 cites W2115524476 @default.
- W2076562457 cites W2143773220 @default.
- W2076562457 cites W2164283469 @default.
- W2076562457 doi "https://doi.org/10.1128/aac.38.10.2398" @default.
- W2076562457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/284751" @default.
- W2076562457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7840577" @default.
- W2076562457 hasPublicationYear "1994" @default.
- W2076562457 type Work @default.
- W2076562457 sameAs 2076562457 @default.
- W2076562457 citedByCount "10" @default.
- W2076562457 crossrefType "journal-article" @default.
- W2076562457 hasAuthorship W2076562457A5022348442 @default.
- W2076562457 hasAuthorship W2076562457A5030716811 @default.
- W2076562457 hasAuthorship W2076562457A5041636907 @default.
- W2076562457 hasAuthorship W2076562457A5045487241 @default.
- W2076562457 hasBestOaLocation W20765624572 @default.
- W2076562457 hasConcept C137061746 @default.
- W2076562457 hasConcept C151730666 @default.
- W2076562457 hasConcept C159047783 @default.
- W2076562457 hasConcept C202751555 @default.
- W2076562457 hasConcept C203014093 @default.
- W2076562457 hasConcept C2522874641 @default.
- W2076562457 hasConcept C2777477808 @default.
- W2076562457 hasConcept C2777995582 @default.
- W2076562457 hasConcept C2778950215 @default.
- W2076562457 hasConcept C2780216070 @default.
- W2076562457 hasConcept C2780727368 @default.
- W2076562457 hasConcept C28406088 @default.
- W2076562457 hasConcept C54355233 @default.
- W2076562457 hasConcept C55493867 @default.
- W2076562457 hasConcept C79879829 @default.
- W2076562457 hasConcept C81885089 @default.
- W2076562457 hasConcept C86803240 @default.
- W2076562457 hasConcept C98274493 @default.
- W2076562457 hasConceptScore W2076562457C137061746 @default.
- W2076562457 hasConceptScore W2076562457C151730666 @default.
- W2076562457 hasConceptScore W2076562457C159047783 @default.
- W2076562457 hasConceptScore W2076562457C202751555 @default.
- W2076562457 hasConceptScore W2076562457C203014093 @default.
- W2076562457 hasConceptScore W2076562457C2522874641 @default.
- W2076562457 hasConceptScore W2076562457C2777477808 @default.
- W2076562457 hasConceptScore W2076562457C2777995582 @default.
- W2076562457 hasConceptScore W2076562457C2778950215 @default.
- W2076562457 hasConceptScore W2076562457C2780216070 @default.
- W2076562457 hasConceptScore W2076562457C2780727368 @default.
- W2076562457 hasConceptScore W2076562457C28406088 @default.
- W2076562457 hasConceptScore W2076562457C54355233 @default.
- W2076562457 hasConceptScore W2076562457C55493867 @default.
- W2076562457 hasConceptScore W2076562457C79879829 @default.
- W2076562457 hasConceptScore W2076562457C81885089 @default.
- W2076562457 hasConceptScore W2076562457C86803240 @default.
- W2076562457 hasConceptScore W2076562457C98274493 @default.
- W2076562457 hasIssue "10" @default.
- W2076562457 hasLocation W20765624571 @default.
- W2076562457 hasLocation W20765624572 @default.
- W2076562457 hasLocation W20765624573 @default.
- W2076562457 hasOpenAccess W2076562457 @default.
- W2076562457 hasPrimaryLocation W20765624571 @default.
- W2076562457 hasRelatedWork W1531068485 @default.
- W2076562457 hasRelatedWork W1608344579 @default.
- W2076562457 hasRelatedWork W1820808323 @default.
- W2076562457 hasRelatedWork W2001836889 @default.
- W2076562457 hasRelatedWork W2006042633 @default.
- W2076562457 hasRelatedWork W2056473717 @default.
- W2076562457 hasRelatedWork W2076562457 @default.
- W2076562457 hasRelatedWork W2090251528 @default.
- W2076562457 hasRelatedWork W2103905263 @default.
- W2076562457 hasRelatedWork W2119739349 @default.